New study aims to map relapse and life quality in rare gynecologic cancers

NCT ID NCT07179757

Recruiting now Knowledge-focused Sponsor: Tata Memorial Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will follow 200 patients with vulvovaginal cancer who received radiation therapy (with or without chemotherapy) to see how the disease returns and how their quality of life changes over time. Researchers will also look at certain biological markers. The goal is to gather better data on these rare cancers to guide future research and treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could identify key areas for future clinical trials and improve understanding of treatment outcomes in vulvovaginal cancers.
What could go wrong: This is an observational study, not a treatment trial. It cannot directly improve patient outcomes, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VAGINAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

vaginal cancer vulva cancer vulvar carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VULVO-VAGINAL CANCER

Contacts and locations

Locations

Tata Memorial Hospital
RECRUITING

Mumbai, Maharashtra, 400012, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.